INTERPRETIVE CRITERIA FOR SUSCEPTIBILITY TESTS WITH DU-6859A AND FK-037 TESTED AGAINST HAEMOPHILUS-INFLUENZAE AND NEISSERIA-GONORRHOEAE

被引:7
作者
JONES, RN
BARRETT, MS
BIEDENBACH, DJ
机构
[1] Anti-Infectives Research Center, Medical Microbiology Division, Department of Pathology, Iowa City, IA
关键词
D O I
10.1016/0732-8893(94)90119-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Preliminary susceptibility testing interpretive criteria were determined for two investigational drugs, DU-6859a and FK-037, when tested against Haemophilus influenzae and Neisseria gonorrhoeae strains. National Committee for Clinical Laboratory Standards (NCCLS) methods with the Haemophilus Test Medium and GC agar base were utilized, and the study design conformed to the NCCLS M23-A guidelines. The proposed H. influenzae susceptibility testing criteria were for DU-6859a susceptible at less than or equal to 1 mu g/ml (5-mu g disk zone diameter correlate, greater than or equal to 19 mm) or less than or equal to 2 mu g/ml (disk zone diameter correlate, greater than or equal to 16 mm) and for FK-037 susceptible al less than or equal to 2 mu g/ml (30-mu g disk zone diameter correlate, greater than or equal to 19 mm). No other susceptibility categories were proposed. The gonococcal susceptibility testing criteria were for DU-6859a susceptible at less than or equal to 0.12 mu g/ml (disk zone diameter correlate, greater than or equal to 34 mm) and for FK-037 susceptible at less than or equal to 0.5 mu g/ml (disk zone diameter correlate, greater than or equal to 30 mm) and resistant at >1 mu g/ml (disk zone diameter correlate, less than or equal to 26 mm). No resistant criterion was proposed for N. gonorrhoeae tests with DU-6859a. No interpretive dis crepancies were observed between methods using these proposed testing criteria.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 14 条
[1]   INTERPRETIVE CRITERIA FOR CI-960, FLEROXACIN AND TEMAFLOXACIN SUSCEPTIBILITY TESTS WITH HAEMOPHILUS-INFLUENZAE [J].
BARRETT, MS ;
JONES, RN .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (05) :462-465
[2]   INTERPRETIVE CRITERIA FOR SUSCEPTIBILITY TESTING OF CI-960 (PD127391, AM-1091), FLEROXACIN, LOMEFLOXACIN, AND TEMAFLOXACIN AGAINST NEISSERIA-GONORRHOEAE, INCLUDING DRUG STABILITY IN GC AGAR MEDIUM [J].
ERWIN, ME ;
JONES, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (05) :1170-1173
[3]   INTERPRETIVE CRITERIA, QUALITY-CONTROL GUIDELINES, AND DRUG STABILITY STUDIES FOR SUSCEPTIBILITY TESTING OF CEFOTAXIME, CEFOXITIN, CEFTAZIDIME, AND CEFUROXIME AGAINST NEISSERIA-GONORRHOEAE [J].
JONES, RN ;
FUCHS, PC ;
WASHINGTON, JA ;
GAVAN, TL ;
MURRAY, PR ;
GERLACH, EH ;
THORNSBERRY, C .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1990, 13 (06) :499-507
[5]  
JONES RN, 1994, IN PRESS DIAGN MICRO
[6]  
JONES RN, 1993, IN PRESS J ANTIMICRO
[7]   IN-VITRO ACTIVITY OF DU-6859A, A NEW FLUOROCYCLOPROPYL QUINOLONE [J].
MARSHALL, SA ;
JONES, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (12) :2747-2753
[8]   INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF FK-037, A PARENTERAL CEPHALOSPORIN [J].
NEU, HC ;
CHIN, NX ;
HUANG, HB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) :566-573
[9]   ANTIMICROBIAL ACTIVITY OF DU-6859, A NEW POTENT FLUOROQUINOLONE, AGAINST CLINICAL ISOLATES [J].
SATO, K ;
HOSHINO, K ;
TANAKA, M ;
HAYAKAWA, I ;
OSADA, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1491-1498
[10]  
WOLFSON J S, 1992, Clinical Microbiology Newsletter, V14, P1, DOI 10.1016/0196-4399(92)90091-M